DBV Technologies SA (DBVT)
21.34
+0.73
(+3.54%)
USD |
NASDAQ |
Apr 17, 16:00
21.33
-0.01
(-0.05%)
After-Hours: 20:00
DBV Technologies SG&A Expense (Quarterly) : 12.79M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| EDAP TMS SA | 13.22M |
| Cellectis SA | 4.798M |
| Akari Therapeutics Plc | 2.138M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 1.472M |